Mansour M, Schwartz D, Judd R, Akingbemi B, Braden T, Morrison E, Dennis J, Bartol FF, Hazi A, Napier I, Abdel-Mageed AB. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer. Intl J Oncology 38(2):537-546, 2011.
Plaisance EP, Lukasova M, Offermanns S, Judd RL. Niacin stimulates adiponectin secretion through the GPR109A Receptor. American Journal of Physiology-Endocrinology and Metabolism296:E549-E558, 2009.
Plaisance EP, Grandjean PW, Brunson BL, Judd RL. Increased total and high-molecular weight adiponectin after extended-release niacin. Metabolism 57:404-409, 2008.
Wang J, Wernette C, Judd RL, White BD. Guanethidine treatment does not block the ability of central leptin administration to decrease blood glucose concentrations in streptozotocin-induced diabetic rats, Journal of Endocrinology 198(3):541-854, 2008.
Mansour M, Goyal HO, Braden TD, Dennis JC, Schwartz D, Judd RL, Bartol FF, Coleman E, Morrison EE. Activation of penile pro-adipogenic peroxisome proliferator-activated receptor with an estrogen: interaction with estrogen receptor α during postnatal development. PPAR Research 2008:651419, 2008.
Brunson BL, Zhong Q, Clarke KJ, Bedi D, Braden TD, Van Santen E, Judd RL. Characterization of adiponectin in the dog. American Journal of Veterinary Research 68 (1):57-62, 2007.
Ding Y, Zuo R, Judd RL, Zhong, J. Endothelin-1 receptor blockade prevented the electrophysiological dysfunction in cardiac myocytes of streptozotocin-induced diabetic rats. Endocrine 30:121-127, 2006.
Bedi D, Clarke KJ, Dennis JC, Zhong Q, Brunson BL, Morrison EE, Judd RL. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Biochemical and Biophysical Research Communications 345:332-339, 2006.
Ding Y, Zuo R, Judd RL, Zhong J. Effects of gender differences on cardiac myocyte dysfunction in streptozotocin-induced diabetic rats. Endocrinology 29(1):135-141, 2006.
Ding Y, Zuo R, Judd RL, Schwartz DD, Zhong J. Contribution of endothelin-1 in cardiac myocyte dysfunction in type 1 diabetic rats. J Card-Renal Res 1:23-32, 2005.
Dennis JC, Coleman ES, Swyers SE, Moody SW, Wright JC, Judd RL, Morrison EE. Changes in mitotic rate and GFAP expression in the primary olfactory acis of Streptozotocin-induced diabetic rats. J Neurocytology 34:3-10, 2005.
Coleman ES, Judd RL, Hoe LL, Dennis JC, Posner PP. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48:166-178, 2004.
Clarke KJ, Zhong Q, Schwartz DD, Coleman ES, Kemppainen RJ, Judd RL. Regulation of adiponectin secretion by endothelin-1. Biochemical and Biophysical Research Communications 312:945-949, 2003.
Zhong Q, Lin CY, Clarke KJ, Kemppainen RJ, Schwartz DD, Judd RL. Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 296:383-387, 2002.
Lin CY, Higginbotham DH, Judd RL, White BD. Central leptin increases insulin sensitivity and normalizes blood glucose concentrations in streptozotocin-treated diabetic rats. American Journal of Physiology-Endocrinol Metab 282:E1084-E1091, 2002.
Raman P, Judd RL. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis. European Journal of Pharmacology 409(1):19-29, 2000.
Judd RL. KRH-594-A Review. Cardiovascular, Pulmonary and Renal Investigational Drugs 1(3):412-415, 1999.
Coppack SW, Perrson M, Judd RL, Miles JM. Glycerol and non-esterified fatty acid metabolism in human muscle and adipose tissue in vivo. American Journal of Physiology 276(39):E233-E240, 1999.
